Function Oncology - Crunchbase Company Profile & Funding

Q: Who invested in Function Oncology?

Function Oncology has 4 investors including Casdin Capital And Alexandria Venture Investments.

Q: When was the last funding round for Function Oncology?

Function Oncology closed its last funding round on obfuscated from a Series A round.

Q: How much funding has Function Oncology raised to date?

Function Oncology has raised obfuscated.

Overview

Function Oncology

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Function Oncology

CB Rank

36543

Function Oncology is a precision medicine company advancing a CRISPR-powered personalized functional genomics platform.

Founded

obfuscation

Private

Series A

San Diego, California, United States

1-10

functiononcology.com

Biotechnology

Genetics

Oncology

Precision Medicine

Therapeutics

Funding Rounds

Series A

OBF

obfuscation

Key People

Srihari Sampath: Co-Founder and CSO
Christian Schmedt: Co-Founder

Details

Legal Name

Function Oncology, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Christian Schmedt, Srihari Sampath, Srinath Sampath

About the Company

Function Oncology is a precision medicine company advancing a CRISPR-powered personalized functional genomics platform to transform the future of targeted cancer treatment.

Contact Email

info@fxonc.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

CRISPR-powered Personalized Functional Genomics Platform

A platform that uses CRISPR technology to assess gene function directly in patient cancer cells, identifying therapeutic targets and vulnerabilities unique to each patient.

Research & Development

Function Oncology is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Function Oncology	4	obfuscated obfuscation	Andreessen Horowitz, S32	Series A
obfuscated obfuscation	Series A - Function Oncology	4	obfuscated obfuscation	Andreessen Horowitz, S32	Series A
obfuscated obfuscation	Series A - Function Oncology	4	obfuscated obfuscation	Andreessen Horowitz, S32	Series A
obfuscated obfuscation	Series A - Function Oncology	4	obfuscated obfuscation	Andreessen Horowitz, S32	Series A
obfuscated obfuscation	Series A - Function Oncology	4	obfuscated obfuscation	Andreessen Horowitz, S32	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Function Oncology	4	obfuscated obfuscation	Andreessen Horowitz, S32	Series A
obfuscated obfuscation	Series A - Function Oncology	4	obfuscated obfuscation	Andreessen Horowitz, S32	Series A
obfuscated obfuscation	Series A - Function Oncology	4	obfuscated obfuscation	Andreessen Horowitz, S32	Series A
obfuscated obfuscation	Series A - Function Oncology	4	obfuscated obfuscation	Andreessen Horowitz, S32	Series A
obfuscated obfuscation	Series A - Function Oncology	4	obfuscated obfuscation	Andreessen Horowitz, S32	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Casdin Capital	—	Series A - Function Oncology	Ryan Blicker
Casdin Capital	—	Series A - Function Oncology	Ryan Blicker
Casdin Capital	—	Series A - Function Oncology	Ryan Blicker
Casdin Capital	—	Series A - Function Oncology	Ryan Blicker
Casdin Capital	—	Series A - Function Oncology	Ryan Blicker